How do I find recruiting Systemic Lupus Erythematosus clinical trials?

Browse the actively recruiting Systemic Lupus Erythematosus studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.

Are Systemic Lupus Erythematosus clinical trials free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

Who can take part in a Systemic Lupus Erythematosus clinical trial?

Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.

Systemic Lupus Erythematosus Clinical Trials

Systemic Lupus Erythematosus clinical trials study new biologics, small-molecule drugs, and treatment approaches for systemic Lupus Erythematosus and related immune or inflammatory conditions. Corterve gathers actively recruiting Systemic Lupus Erythematosus studies from ClinicalTrials.gov so you can browse by location and eligibility. This is general information, not medical advice — talk with your specialist before enrolling in a study.

Browse all Systemic Lupus Erythematosus trials Take the assessment

Recruiting Systemic Lupus Erythematosus studies

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
NCT06434363PHASE1, PHASE2M.D. Anderson Cancer CenterAutoimmune DisordersHouston, Texas
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
NCT07332481PHASE3EMD Serono Research & Development Institute, Inc.Systemic Lupus Erythematosus (SLE)Los Angeles, California
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
NCT06121297PHASE1, PHASE2Cabaletta BioSystemic Lupus ErythematosusOrange, California
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
NCT03816345PHASE1National Cancer Institute (NCI)Autoimmune DiseaseBirmingham, Alabama
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
NCT07260877PHASE2Ventus Therapeutics U.S., Inc.Cutaneous Lupus Erythematosus (CLE)Beverly Hills, California
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
NCT06570798PHASE2AmgenSystemic Lupus ErythematosusScottsdale, Arizona
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
NCT07691970PHASE3AstraZenecaSystemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus ErythematosusPhoenix, Arizona
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
NCT06617325PHASE3UCB Biopharma SRLSystemic Lupus ErythematosusAvondale, Arizona
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
NCT06133972PHASE3Novartis PharmaceuticalsSystemic Lupus ErythematosusAnniston, Alabama
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
NCT07409181PHASE2Boehringer IngelheimSystemic Lupus ErythematosusBeverly Hills, California
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
NCT05835310PHASE3AstraZenecaSystemic Lupus ErythematosusPhoenix, Arizona
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
NCT05567198National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Systemic Lupus Erythematosus (Sle)Bethesda, Maryland

See all 59 recruiting trials →

Systemic Lupus Erythematosus trials by state

Systemic Lupus Erythematosus trials by metro

Frequently asked questions

How do I find recruiting Systemic Lupus Erythematosus clinical trials?: Browse the actively recruiting Systemic Lupus Erythematosus studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
Are Systemic Lupus Erythematosus clinical trials free to join?: Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
Who can take part in a Systemic Lupus Erythematosus clinical trial?: Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.